FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Vet Anaesth Analg / Metabolism, pharmacokinetics and selected pharmacodynamic ef...
Veterinary anaesthesia and analgesia2020; 47(5); 694-704; doi: 10.1016/j.vaa.2020.04.004

Metabolism, pharmacokinetics and selected pharmacodynamic effects of codeine following a single oral administration to horses.

Abstract: To describe the pharmacokinetics and selected pharmacodynamic variables of codeine and its metabolites in Thoroughbred horses following a single oral administration. Methods: Prospective experimental study. Methods: A total of 12 Thoroughbred horses, nine geldings and three mares, aged 4-8 years. Methods: Horses were administered codeine (0.6 mg kg) orally and blood was collected before administration and at various times until 120 hours post administration. Plasma and urine samples were collected and analyzed for codeine and its metabolites by liquid chromatography-mass spectrometry, and plasma pharmacokinetics were determined. Heart rate and rhythm, step counts, packed cell volume and total plasma protein were measured before and 4 hours after administration. Results: Codeine was rapidly converted to the metabolites norcodeine, codeine-6-glucuronide (C6G), morphine, morphine-3-glucuronide (M3G) and morphine-6-glucuronide (M6G). Plasma codeine concentrations were best represented using a two-compartment model. The C t and elimination t were 270.7 ± 136.0 ng mL, 0.438 ± 0.156 hours and 2.00 ± 0.534 hours, respectively. M3G was the main metabolite detected (C 492.7 ± 35.5 ng mL), followed by C6G (C 96.1 ± 33.8 ng mL) and M6G (C 22.3 ± 4.96 ng mL). Morphine and norcodeine were the least abundant metabolites with C of 3.17 ± 0.95 and 1.42 ± 0.79 ng mL, respectively. No significant adverse or excitatory effects were observed. Conclusions: Following oral administration, codeine is rapidly metabolized to morphine, M3G, M6G, C6G and norcodeine in horses. Plasma concentrations of M6G, a presumed active metabolite of morphine, were comparable to concentrations reported previously following administration of an analgesic dose of morphine to horses. Codeine was well tolerated based on pharmacodynamic variables and behavioral observations.
Copyright © 2020 Association of Veterinary Anaesthetists and American College of Veterinary Anesthesia and Analgesia. Published by Elsevier Ltd. All rights reserved.
Get Full Text
Publication Date: 2020-04-23 PubMed ID: 32654915PubMed Central: PMC7872472DOI: 10.1016/j.vaa.2020.04.004Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research study focuses on the metabolism, pharmacokinetics, and selected pharmacodynamic variables of Codeine in Thoroughbred horses following a single oral administration.

Research Methodology

  • The study recruited 12 Thoroughbred horses as test subjects, consisting of nine geldings and three mares, aged between 4-8 years.
  • Each horse was administered a single oral dose of Codeine.
  • Blood samples were collected at set intervals until 120 hours following the administration to monitor the behavior of the drug in the bloodstream.
  • Plasma and urine samples were then analyzed for the presence of Codeine and its metabolites using liquid chromatography-mass spectrometry, providing insight into the drug’s pharmacokinetics.
  • Various physiological measures, including heart rate, step counts, and packed cell volumes, were recorded before and 4 hours after Codeine administration to assess the drug’s pharmacodynamic effects.

Research Findings

  • Codeine was found to be rapidly metabolized into various compounds, including norcodeine, codeine-6-glucuronide (C6G), morphine, morphine-3-glucuronide (M3G), and morphine-6-glucuronide (M6G).
  • The drug’s presence in the plasma was best represented by a two-compartment model, implying that it is distributed in more than one area of the body.
  • M3G was the primary metabolite detected, followed by C6G and M6G. Morphine and norcodeine recorded the least concentrations.
  • No significant adverse or excitatory effects were observed post-administration, demonstrating that Codeine was well-tolerated by the horses.

Research Conclusions

  • Codeine is quickly transformed into morphine, M3G, M6G, C6G and norcodeine following oral administration in horses.
  • The plasma concentrations of M6G, an assumed active metabolite of Morphine, were comparable to concentrations previously reported after analgesic doses of Morphine were administered to horses.
  • Based on both the physiological measures recorded and behavioral observations, Codeine was found to be well-tolerated by the horses.

Cite This Article

APA
Gretler SR, Finno CJ, McKemie DS, Kass PH, Knych HK. (2020). Metabolism, pharmacokinetics and selected pharmacodynamic effects of codeine following a single oral administration to horses. Vet Anaesth Analg, 47(5), 694-704. https://doi.org/10.1016/j.vaa.2020.04.004

Publication

Veterinary anaesthesia and analgesia
ISSN: 1467-2995
NlmUniqueID: 100956422
Country: United States
Language: English
Volume: 47
Issue: 5
Pages: 694-704
PII: S1467-2987(20)30083-0

Researcher Affiliations

Gretler, Sophie R
  • K.L. Maddy Equine Analytical Pharmacology Laboratory, University of California-Davis, School of Veterinary Medicine, Davis, CA, USA.
Finno, Carrie J
  • Department of Population Health and Reproduction, School of Veterinary Medicine, University of California, Davis, CA, USA.
McKemie, Daniel S
  • K.L. Maddy Equine Analytical Pharmacology Laboratory, University of California-Davis, School of Veterinary Medicine, Davis, CA, USA.
Kass, Philip H
  • Department of Population Health and Reproduction, School of Veterinary Medicine, University of California, Davis, CA, USA.
Knych, Heather K
  • K.L. Maddy Equine Analytical Pharmacology Laboratory, University of California-Davis, School of Veterinary Medicine, Davis, CA, USA; Department of Veterinary Molecular Biosciences, School of Veterinary Medicine, University of California, Davis, CA, USA. Electronic address: hkknych@ucdavis.edu.

MeSH Terms

  • Administration, Oral
  • Animals
  • Area Under Curve
  • Codeine / blood
  • Codeine / metabolism
  • Codeine / pharmacokinetics
  • Codeine / urine
  • Drug Administration Schedule
  • Female
  • Half-Life
  • Horses / metabolism
  • Male

Grant Funding

  • L40 TR001136 / NCATS NIH HHS

Conflict of Interest Statement

Conflict of interest statement. The authors declare no conflict of interest

References

This article includes 40 references
  1. Barnett M. Alternative opioids to morphine in palliative care: a review of current practice and evidence.. Postgrad Med J 2001 Jun;77(908):371-8.
    pmc: PMC1742058pubmed: 11375449doi: 10.1136/pmj.77.908.371google scholar: lookup
  2. Chen ZR, Somogyi AA, Reynolds G, Bochner F. Disposition and metabolism of codeine after single and chronic doses in one poor and seven extensive metabolisers.. Br J Clin Pharmacol 1991 Apr;31(4):381-90.
    pmc: PMC1368322pubmed: 2049245doi: 10.1111/j.1365-2125.1991.tb05550.xgoogle scholar: lookup
  3. Clutton RE. Opioid analgesia in horses.. Vet Clin North Am Equine Pract 2010 Dec;26(3):493-514.
    pubmed: 21056296doi: 10.1016/j.cveq.2010.07.002google scholar: lookup
  4. Combie J, Shults T, Nugent EC, Dougherty J, Tobin T. Pharmacology of narcotic analgesics in the horse: selective blockade of narcotic-induced locomotor activity.. Am J Vet Res 1981 May;42(5):716-21.
    pubmed: 6114692
  5. Corado CR, McKemie DS, Knych HK. Dextromethorphan and debrisoquine metabolism and polymorphism of the gene for cytochrome P450 isozyme 2D50 in Thoroughbreds.. Am J Vet Res 2016 Sep;77(9):1029-35.
    pubmed: 27580115doi: 10.2460/ajvr.77.9.1029google scholar: lookup
  6. Corado CR, McKemie DS, Knych HK. Pharmacokinetics of dextromethorphan and its metabolites in horses following a single oral administration.. Drug Test Anal 2017 Jun;9(6):880-887.
    pubmed: 27580591doi: 10.1002/dta.2060google scholar: lookup
  7. Dean L. Codeine therapy and CYP2D6 genotype. Medical Genetics Summaries pp. 1–9.
  8. Findlay JWA, Jones EC, Butz RF, Welch RM. Plasma codeine and morphine concentrations after therapeutic oral doses of codeine-containing analgesics. Clin Pharmacol Ther 24, 60–68.
    pubmed: 0
  9. Findlay JW, Fowle AS, Butz RF, Jones EC, Weatherley BC, Welch RM, Posner J. Comparative disposition of codeine and pholcodine in man after single oral doses.. Br J Clin Pharmacol 1986 Jul;22(1):61-71.
    pmc: PMC1401076pubmed: 3741728doi: 10.1111/j.1365-2125.1986.tb02881.xgoogle scholar: lookup
  10. Frances B, Gout R, Monsarrat B, Cros J, Zajac JM. Further evidence that morphine-6 beta-glucuronide is a more potent opioid agonist than morphine.. J Pharmacol Exp Ther 1992 Jul;262(1):25-31.
    pubmed: 1320685
  11. Fuller RW, Jackson DM. Physiology and treatment of cough.. Thorax 1990 Jun;45(6):425-30.
    pmc: PMC462522pubmed: 2203180doi: 10.1136/thx.45.6.425google scholar: lookup
  12. Gaynor JS. Control of cancer pain in veterinary patients.. Vet Clin North Am Small Anim Pract 2008 Nov;38(6):1429-48, viii.
    pubmed: 18954691doi: 10.1016/j.cvsm.2008.06.009google scholar: lookup
  13. Grace D, Fee JP. A comparison of intrathecal morphine-6-glucuronide and intrathecal morphine sulfate as analgesics for total hip replacement.. Anesth Analg 1996 Nov;83(5):1055-9.
    pubmed: 8895285doi: 10.1097/00000539-199611000-00027google scholar: lookup
  14. Guay DR, Awni WM, Halstenson CE, Findlay JW, Opsahl JA, Abraham PA, Jones EC, Matzke GR. Pharmacokinetics of codeine after single- and multiple-oral-dose administration to normal volunteers.. J Clin Pharmacol 1987 Dec;27(12):983-7.
    pubmed: 3437070doi: 10.1002/j.1552-4604.1987.tb05601.xgoogle scholar: lookup
  15. Hamamoto-Hardman BD, Steffey EP, Weiner D, McKemie DS, Kass P, Knych HK. Pharmacokinetics and selected pharmacodynamics of morphine and its active metabolites in horses after intravenous administration of four doses.. J Vet Pharmacol Ther 2019 Jul;42(4):401-410.
    pubmed: 30919469doi: 10.1111/jvp.12759google scholar: lookup
  16. Yoshimura H, Mori MA, Oguri K, Tsukamoto H. Metabolism of drugs-LXV. Studies on the urinary conjugated metabolites of codeine.. Biochem Pharmacol 1970 Jul;19(7):2353-60.
    pubmed: 5520378doi: 10.1016/0006-2952(70)90134-6google scholar: lookup
  17. Kirchheiner J, Schmidt H, Tzvetkov M, Keulen JT, Lötsch J, Roots I, Brockmöller J. Pharmacokinetics of codeine and its metabolite morphine in ultra-rapid metabolizers due to CYP2D6 duplication.. Pharmacogenomics J 2007 Aug;7(4):257-65.
    pubmed: 16819548doi: 10.1038/sj.tpj.6500406google scholar: lookup
  18. Knych HK. Nonsteroidal Anti-inflammatory Drug Use in Horses.. Vet Clin North Am Equine Pract 2017 Apr;33(1):1-15.
    pubmed: 28190614doi: 10.1016/j.cveq.2016.11.001google scholar: lookup
  19. Knych HK, Steffey EP, McKemie DS. Preliminary pharmacokinetics of morphine and its major metabolites following intravenous administration of four doses to horses.. J Vet Pharmacol Ther 2014 Aug;37(4):374-81.
    pubmed: 24479785doi: 10.1111/jvp.12098google scholar: lookup
  20. Knych HK, Baden RW, Gretler SR, McKemie DS. Characterization of the in vitro CYP450 mediated metabolism of the polymorphic CYP2D6 probe drug codeine in horses.. Biochem Pharmacol 2019 Oct;168:184-192.
    pubmed: 31295464doi: 10.1016/j.bcp.2019.07.005google scholar: lookup
  21. KuKanich B. Pharmacokinetics of acetaminophen, codeine, and the codeine metabolites morphine and codeine-6-glucuronide in healthy Greyhound dogs.. J Vet Pharmacol Ther 2010 Feb;33(1):15-21.
    pmc: PMC2867071pubmed: 20444020doi: 10.1111/j.1365-2885.2009.01098.xgoogle scholar: lookup
  22. Lötsch J, Geisslinger G. Morphine-6-glucuronide: an analgesic of the future?. Clin Pharmacokinet 2001;40(7):485-99.
    pubmed: 11510626doi: 10.2165/00003088-200140070-00001google scholar: lookup
  23. Madadi P, Koren G. Pharmacogenetic insights into codeine analgesia: implications to pediatric codeine use.. Pharmacogenomics 2008 Sep;9(9):1267-84.
    pubmed: 18781855doi: 10.2217/14622416.9.9.1267google scholar: lookup
  24. Mama KR, Pascoe PJ, Steffey EP. Evaluation of the interaction of mu and kappa opioid agonists on locomotor behavior in the horse.. Can J Vet Res 1993 Apr;57(2):106-9.
    pmc: PMC1263602pubmed: 8490803
  25. Martínez Aranzales JR, Cândido de Andrade BS, Silveira Alves GE. Orally administered phenylbutazone causes oxidative stress in the equine gastric mucosa.. J Vet Pharmacol Ther 2015 Jun;38(3):257-64.
    pubmed: 25287371doi: 10.1111/jvp.12168google scholar: lookup
  26. Martins TL, Kahvegian MA, Noel-Morgan J, Leon-Román MA, Otsuki DA, Fantoni DT. Comparison of the effects of tramadol, codeine, and ketoprofen alone or in combination on postoperative pain and on concentrations of blood glucose, serum cortisol, and serum interleukin-6 in dogs undergoing maxillectomy or mandibulectomy.. Am J Vet Res 2010 Sep;71(9):1019-26.
    pubmed: 20807140doi: 10.2460/ajvr.71.9.1019google scholar: lookup
  27. Oguri K, Hanioka N, Yoshimura H. Species differences in metabolism of codeine: urinary excretion of codeine glucuronide, morphine-3-glucuronide and morphine-6-glucuronide in mice, rats, guinea pigs and rabbits.. Xenobiotica 1990 Jul;20(7):683-8.
    pubmed: 2238703doi: 10.3109/00498259009046884google scholar: lookup
  28. Paul D, Standifer KM, Inturrisi CE, Pasternak GW. Pharmacological characterization of morphine-6 beta-glucuronide, a very potent morphine metabolite.. J Pharmacol Exp Ther 1989 Nov;251(2):477-83.
    pubmed: 2810109
  29. Poliacek I, Simera M, Veternik M, Kotmanova Z, Bolser DC, Machac P, Jakus J. Role of the dorsomedial medulla in suppression of cough by codeine in cats.. Respir Physiol Neurobiol 2017 Dec;246:59-66.
    pmc: PMC5646267pubmed: 28778649doi: 10.1016/j.resp.2017.07.011google scholar: lookup
  30. Poulsen L, Brøsen K, Arendt-Nielsen L, Gram LF, Elbaek K, Sindrup SH. Codeine and morphine in extensive and poor metabolizers of sparteine: pharmacokinetics, analgesic effect and side effects.. Eur J Clin Pharmacol 1996;51(3-4):289-95.
    pubmed: 9010701doi: 10.1007/s002280050200google scholar: lookup
  31. Dönselmann Im Sande P, Hopster K, Kästner S. [Effects of morphine, butorphanol and levomethadone in different doses on thermal nociceptive thresholds in horses].. Tierarztl Prax Ausg G Grosstiere Nutztiere 2017 Apr 19;45(2):98-106.
    pubmed: 28075433doi: 10.15653/tpg-160655google scholar: lookup
  32. Shimomura K, Kamata O, Ueki S, Ida S, Oguri K, Yoshimura H, Tsukamoto H. Analgesic effect of morphine glucuronides.. Tohoku J Exp Med 1971 Sep;105(1):45-52.
    pubmed: 5140097doi: 10.1620/tjem.105.45google scholar: lookup
  33. Sindrup SH, Brøsen K. The pharmacogenetics of codeine hypoalgesia.. Pharmacogenetics 1995 Dec;5(6):335-46.
    pubmed: 8845855doi: 10.1097/00008571-199512000-00001google scholar: lookup
  34. Sindrup SH, Arendt-Nielsen L, Brøsen K, Bjerring P, Angelo HR, Eriksen B, Gram LF. The effect of quinidine on the analgesic effect of codeine.. Eur J Clin Pharmacol 1992;42(6):587-91.
    pubmed: 1623898doi: 10.1007/bf00265920google scholar: lookup
  35. Srinivasan V, Wielbo D, Tebbett IR. Analgesic effects of codeine-6-glucuronide after intravenous administration.. Eur J Pain 1997;1(3):185-90.
    pubmed: 15102399doi: 10.1016/s1090-3801(97)90103-8google scholar: lookup
  36. Stain F, Barjavel MJ, Sandouk P, Plotkine M, Scherrmann JM, Bhargava HN. Analgesic response and plasma and brain extracellular fluid pharmacokinetics of morphine and morphine-6-beta-D-glucuronide in the rat.. J Pharmacol Exp Ther 1995 Aug;274(2):852-7.
    pubmed: 7636748
  37. Tasker JB. Fluid and electrolyte studies in the horse. I. Blood values in 100 normal horses.. Cornell Vet 1966 Jan;56(1):67-76.
    pubmed: 5950941
  38. Williams DG, Hatch DJ, Howard RF. Codeine phosphate in paediatric medicine.. Br J Anaesth 2001 Mar;86(3):413-21.
    pubmed: 11573533doi: 10.1093/bja/86.3.413google scholar: lookup
  39. Yeh SY, Woods LA. Excretion of codeine and its metabolites by dogs, rabbits and cats.. Arch Int Pharmacodyn Ther 1971 Jun;191(2):231-42.
    pubmed: 5089213
  40. Yoshimura H, Ida S, Oguri K, Tsukamoto H. Biochemical basis for analgesic activity of morphine-6-glucuronide. I. Penetration of morphine-6-glucuronide in the brain of rats.. Biochem Pharmacol 1973 Jun 15;22(12):1423-30.
    pubmed: 4732523doi: 10.1016/0006-2952(73)90320-1google scholar: lookup

Citations

This article has been cited 2 times.
  1. Knych HK, Stucker K, Gretler SR, Kass PH, McKemie DS. Pharmacokinetics, adverse effects and effects on thermal nociception following administration of three doses of codeine to horses.. BMC Vet Res 2022 May 25;18(1):196.
    doi: 10.1186/s12917-022-03299-0pubmed: 35614473google scholar: lookup
  2. Gretler SR, Finno CJ, Kass PH, Knych HK. Functional phenotyping of the CYP2D6 probe drug codeine in the horse.. BMC Vet Res 2021 Feb 13;17(1):77.
    doi: 10.1186/s12917-021-02788-ypubmed: 33581736google scholar: lookup
Subscribe to our newsletter
Join 99,344 horse owners like you who receive our email updates on horse health and nutrition.